Citation Impact
Citing Papers
Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation
2007 StandoutScience
Untangling the ErbB signalling network
2001 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics
2011 Standout
Point mutations of the N‐ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia
1994
Combined Immunodeficiencies with Nonfunctional T Lymphocytes
2014
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
1998 Standout
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
1990 StandoutNature
Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro
2003
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
2007 Standout
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
Differentiation of fetal osteoblasts and formation of mineralized bone nodules by 45S5 Bioglass® conditioned medium in the absence of osteogenic supplements
2009
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
1998 Standout
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
AU-rich transient response transcripts in the human genome: expressed sequence tag clustering and gene discovery approach
2004
Induction of apoptosis in fibroblasts by c-myc protein
1992 Standout
The importance of the viable but non-culturable state in human bacterial pathogens
2014
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
2005 StandoutNobel
The multilayered complexity of ceRNA crosstalk and competition
2014 StandoutNature
Myocyte cell damage after administration of doxorubicin or mitoxantrone in breast cancer patients assessed by indium 111 antimyosin monoclonal antibody studies.
1993
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
1991 StandoutNature
EGF–ERBB signalling: towards the systems level
2006 Standout
Role of the retinoblastoma protein in the pathogenesis of human cancer.
1997 StandoutNobel
Alternative polyadenylation variants of the RNA binding protein, HuR: abundance, role of AU-rich elements and auto-Regulation
2009
Richter syndrome
2004
Biofilms: an emergent form of bacterial life
2016 Standout
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells
2005
Phosphotyrosyl Peptides Block Stat3-mediated DNA Binding Activity, Gene Regulation, and Cell Transformation
2001
Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins
2004
Oncogenic Mutations Counteract Intrinsic Disorder in the EGFR Kinase and Promote Receptor Dimerization
2012 StandoutNobel
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
2005 Standout
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
2013 StandoutNobel
Molecular biology of erythropoietin
1993 StandoutNobel
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Stimulatory effect on bone formation exerted by a modified chitosan
1994
Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis
1990 Nature
STAT proteins: novel molecular targets for cancer drug discovery
2000
MicroRNA signatures in human cancers
2006 Standout
The STATs of cancer — new molecular targets come of age
2004 Standout
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
2010 Standout
Transmembrane crosstalk between the extracellular matrix and the cytoskeleton
2001 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
1991 Standout
Circulating nucleic acids (CNAs) and cancer—A survey
2006
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human Cancer
1996
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 Standout
The sensitivity of c-Jun and c-Fos proteins to calpains depends on conformational determinants of the monomers and not on formation of dimers
1999
Tumor Necrosis Factor-α Promotes In Vitro Calcification of Vascular Cells via the cAMP Pathway
2000
Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization
2002 Standout
Velvet, a Dominant Egfr Mutation That Causes Wavy Hair and Defective Eyelid Development in Mice
2004 StandoutNobel
Regulatory T Cells and Human Disease
2020 StandoutNobel
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Cancer Cell Cycles
1996 StandoutScience
A Functional Link between Dynamin and the Actin Cytoskeleton at Podosomes
2000
Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments
1986
Dose-dependent effects of strontium on osteoblast function and mineralization
2003
The Calpain System
2003 Standout
Pharmacodynamic Studies of the Epidermal Growth Factor Receptor Inhibitor ZD1839 in Skin From Cancer Patients: Histopathologic and Molecular Consequences of Receptor Inhibition
2002
Functional Characterization of Osteoblasts and Osteoclasts from Alkaline Phosphatase Knockout Mice
2000
Retinoblastoma Protein Contains a C-terminal Motif That Targets It for Phosphorylation by Cyclin-cdk Complexes
1999 StandoutNobel
Pharmacodynamic Studies of the Epidermal Growth Factor Receptor Inhibitor ZD1839 in Skin From Cancer Patients: Histopathologic and Molecular Consequences of Receptor Inhibition
2002
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
1999 Standout
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
1985 Standout
Lipid Oxidation Products Have Opposite Effects on Calcifying Vascular Cell and Bone Cell Differentiation
1997
The In Vitro Generation of Effector Lymphocytes and Their Employment in Tumor Immunotherapy
1983
Vascular Calcification
2008 Standout
Mechanisms of Endocytosis
2009 Standout
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Bcl-2 and the regulation of programmed cell death
1994 Standout
Works of Benjamin Klein being referenced
Studies of the Levamisole inhibitory effect on rat stromal‐cell commitment to mineralization
1993
Selection of malonate‐resistant stromal cell‐derived osteoprogenitor cells in vitro
1993
Growth inhibition of psoriatic keratinocytes by quinazoline tyrosine kinase inhibitors
1999
Isolation and hormonal responsiveness of primary cultures of human bone-derived cells: gender and age differences
1999
Structural Changes and Cellular Localization of Resuscitation-Promoting Factor in Environmental Isolates of Micrococcus luteus
2009
Opposing effects on mitochondrial membrane potential by malonate and levamisole, whose effect on cell-mediated mineralization is antagonistic
1996
Successful Long-Term Correction of Autosomal Recessive Hyper-IgE Syndrome due to DOCK8 Deficiency by Hematopoietic Stem Cell Transplantation
2010
Inhibitors of Tyrosine Kinases in the Treatment of Psoriasis
2000
Marrow stromal cell commitment to mineralization under the effect of a prolyl hydroxylase inhibitor
1994
Inhibitors that target protein kinases for the treatment of ovarian carcinoma
2003
SEM observations on the effect of anthracycline drugs on cultured newborn rat cardiomyocytes
1988
Retrovirus-mediated gene transfer of a human c-fos cDNA into mouse bone marrow stromal cells.
1991
Can tumorigenesis result from in vivo “transfection” of a normal cell with DNA escaped from disintegrating nontransformed cells?
1981
Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. I. screening of immunogenic components by isopycnic ultracentrifugation and polyacrylamide electrophoresis of a tumor homogenate
1980
Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle- cell lymphomas and t(11q13)-associated leukemias
1994
Hairy cell transformation of a B-cell chronic lymphocytic leukemia: a morphological, cytochemical, phenotypic and molecular study.
1991
[Transformation by SV 40 virus sensitizes fibroblasts of human skin to the lytic action of H-1 parvovirus].
1985
Cyclosporin A and its non-immunosuppressive derivative exhibit a differential effect on cell-mediated mineralization in culture
1997
Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. II. Stimulation of syngeneic antitumor cell-mediated immune responses by subcellular fractions and molecular species of the Rauscher-virus-induced RBL5 tumor.
1981
Studies on erythroid-committed precursor cells in the polycythaemic mouse.
1977